Compass Therapeutics (CMPX) Accumulated Depreciation & Amortization (2023 - 2025)
Historic Accumulated Depreciation & Amortization for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $6.6 million.
- Compass Therapeutics' Accumulated Depreciation & Amortization fell 142.94% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 142.94%. This contributed to the annual value of $6.4 million for FY2024, which is 149.99% up from last year.
- As of Q3 2025, Compass Therapeutics' Accumulated Depreciation & Amortization stood at $6.6 million, which was down 142.94% from $6.6 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Accumulated Depreciation & Amortization registered a high of $6.7 million during Q3 2024, and its lowest value of $5.8 million during Q1 2023.
- For the 3-year period, Compass Therapeutics' Accumulated Depreciation & Amortization averaged around $6.4 million, with its median value being $6.4 million (2024).
- Per our database at Business Quant, Compass Therapeutics' Accumulated Depreciation & Amortization soared by 1143.7% in 2024 and then plummeted by 142.94% in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Accumulated Depreciation & Amortization stood at $6.3 million in 2023, then grew by 1.5% to $6.4 million in 2024, then increased by 4.07% to $6.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $6.6 million for Q3 2025, versus $6.6 million for Q2 2025 and $6.5 million for Q1 2025.